Emerging therapeutic targets in bladder cancer

BA Carneiro, JJ Meeks, TM Kuzel, M Scaranti… - Cancer Treatment …, 2015 - Elsevier
Abstract Treatment of muscle invasive urothelial bladder carcinoma (BCa) remains a major
challenge. Comprehensive genomic profiling of tumors and identification of driver mutations …

Akt pathway inhibitors

NE Uko, OF Güner, DF Matesic… - Current topics in …, 2020 - ingentaconnect.com
Cancer is a devastating disease that has plagued humans from ancient times to this day.
After decades of slow research progress, promising drug development, and the identification …

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

N Houédé, P Pourquier - Pharmacology & therapeutics, 2015 - Elsevier
Urothelial carcinoma of the bladder is the most frequent tumor of the urinary tract and
represents the fifth cause of death by cancer worldwide. The current first line chemotherapy …

Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy

PA Jaffres, C Gajate, AM Bouchet… - Pharmacology & …, 2016 - Elsevier
Synthetic alkyl lipids, such as the ether lipids edelfosine (1-O-octadecyl-2-O-methyl-rac-
glycero-3-phosphocholine) and ohmline (1-O-hexadecyl-2-O-methyl-rac-glycero-3-β …

ROS/mtROS promotes TNTs formation via the PI3K/AKT/mTOR pathway to protect against mitochondrial damages in glial cells induced by engineered nanomaterials

X Lin, W Wang, X Chang, C Chen, Z Guo, G Yu… - Particle and Fibre …, 2024 - Springer
Background As the demand and application of engineered nanomaterials have increased,
their potential toxicity to the central nervous system has drawn increasing attention …

Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity

NG Sanders, DJ Sullivan, G Mlambo, G Dimopoulos… - PloS one, 2014 - journals.plos.org
Discovery of transmission blocking compounds is an important intervention strategy
necessary to eliminate and eradicate malaria. To date only a small number of drugs that …

Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia

BA Carneiro, JB Kaplan, JK Altman… - Cancer Biology & …, 2015 - Taylor & Francis
An accumulating understanding of the complex pathogenesis of acute myeloid leukemia
(AML) continues to lead to promising therapeutic approaches. Among the key aberrant …

Triggering of eryptosis, the suicidal erythrocyte death, by perifosine

J Egler, F Lang - Cellular Physiology and Biochemistry, 2017 - karger.com
Abstract Background/Aims: The alkylphospholipid perifosine is used for the treatment of
malignancy. The substance is effective by triggering suicidal tumor cell death or apoptosis …

[HTML][HTML] Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities

M Stahl, TK Kim, AM Zeidan - World Journal of Stem Cells, 2016 - ncbi.nlm.nih.gov
The existence of cancer stem cells has been well established in acute myeloid leukemia.
Initial proof of the existence of leukemia stem cells (LSCs) was accomplished by functional …

A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia

Y Chen, X Xie, A Wu, L Wang, Y Hu, H Zhang… - Journal of Experimental & …, 2018 - Springer
Background Oncogenic roles of epidermal growth factor receptor pathway substrate no. 8
(EPS8) have been widely reported in various tumors, making targeting of EPS8 an …